Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ENOV
ENOV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ENOV News
Front Street Capital Increases Stake in Enovis
3d ago
Fool
Front Street Increases Stake in Enovis by 384,124 Shares
3d ago
NASDAQ.COM
Enovis Corporation Q1 Earnings Announcement Scheduled
May 06 2026
seekingalpha
Knoa Pharma Establishes New Board to Enhance Public Health Initiatives
May 01 2026
Newsfilter
The Small-Cap Comeback Could Be Beginning: Here Are Some Funds and Stocks to Consider.
Mar 06 2026
Barron's
Enovis Corporation Reports Q4 2025 Earnings Highlights
Feb 27 2026
seekingalpha
Front Street Capital Increases Enovis Holdings
Feb 26 2026
Fool
Enovis Corporation Set to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Enovis Corporation Rated 'Outperform' by Evercore ISI Despite Weak Stock Performance
Feb 10 2026
Yahoo Finance
Oversold Stocks: Travere, Hims, and Enovis Present Buying Opportunities
Jan 21 2026
Benzinga
Analysts Adjust Ratings on Wealthfront and Spire Global with Price Targets
Jan 06 2026
Benzinga
Enovis Appoints Oliver Engert as Chief Administrative Officer to Drive Strategic Development
Jan 05 2026
Globenewswire
Enovis (ENOV) Insider Makes Significant Investment by Acquiring 2,468 Shares
Dec 08 2025
NASDAQ.COM
Wells Fargo Keeps Overweight Rating on Enovis and Increases Price Target to $42
Nov 07 2025
Benzinga
Inside Look: IJR Projected to Rise by 14%
Oct 27 2025
NASDAQ.COM
Enovis to Host Webcast and Conference Call for Q3 2025 Results and Attend Upcoming Investor Conferences
Oct 24 2025
Newsfilter
Show More News